Publications

News

PTAB: Tribal Sovereign Immunity Does Not Provide a Basis to Terminate IPRs LimeGreen IP News

On February 23, 2018, in a much-anticipated decision, the PTAB ruled that tribal sovereign immunity could not be used to shield certain Allergan Inc. (“Allergan”) patents from...

Published Works

The year ahead for PTAB Intellectual Property Magazine

Joseph Raffetto, Arlene L Chow, and Corey T Leggett contributed an article to Intellectual Property Magazine on the year ahead for PTAB.

News

U.S. Patent Legislation: The STRONGER Patents Act of 2017 LimeGreen IP

In June, three democratic senators (Chris Coons from Delaware, Dick Durbin from Illinois, and Mazie Hirono from Hawaii) and one republican senator (Tom Cotton from Arkansas) introduced the...

News

US: Supreme Court Takes Up Constitutionality of Inter Partes Review LimeGreen IP News

On June 12, 2017, the Supreme Court granted certiorari to decide the constitutionality of inter partes review, a proceeding before the Patent Trial and Appeals Board (PTAB) that allows...

Hogan Lovells Publications

Patents or Trade Secrets? Yes, Please.

Most energy companies implement Intellectual Property (“IP”) strategies to protect and exploit company IP (offense) and navigate third-party rights...

Published Works

Flying High: the PTAB's Pilot Scheme for One-Judge Reviews World Intellectual Property Review

The PTAB's pilot programme for a single judge to evaluate an inter partes review petition has the potential to address several perceived problems with the current process.

Published Works

Recent USPTO Activity May Signal Shift in Treatment of Pharmaceutical Patents in AIA Proceedings Pharmaceutical Online

The America Invents Act provides for adversarial proceedings for challenging patents in the United States Patent and Trademark Office — including inter partes review and post grant review — ...

Loading data